source
- Analysts warn that PD-1/VEGF bispecific drugs may be better suited for liver cancer than lung cancerMany drugmakers have poured billions into PD-1/VEGF bispecific antibodies after ivonescimab beat Keytruda in a 2024 lung‑cancer trial, sparking a wave of deals and development programs. A recent C…
- HHS Office of Human Research Protections faces staff shortages, jeopardizing participant safety oversightIn 2021 the Office of Human Research Protections (OHRP) received a report of a participant suicide during a depression and mobility study at the New York State Psychiatric Institute. The incident p…